This is a randomized, partially-blinded, multi-center, parallel-group study to evaluate and
compare the PD and PK of MPA after a single SC injection of either 45 mg/0.3 mL, 75 mg/0.5 mL
or 105 mg/0.7 mL of Depo-Provera CI, and one cycle of Depo-subQ 104 use when injected in the
abdomen, in women of reproductive age with confirmed ovulatory baseline cycle